FIELD: chemistry.
SUBSTANCE: invention concerns novel compounds of the formula I and their pharmaceutically acceptable salts. Claimed compounds display PPAR agonistic effect. In the general formula I A is O; X is a link or CH2; R1 is selected out of C1-C3alkyl; each R4 is independently selected out of group including halogen or -OC1-C3alkyl, where -OC1-C3alkyl can be optionally substituted by 1-3 F; each R5 is independently selected out of group including F, CI; R6 is selected out of group including C2-C5alkyl and -CH2cyclopropyl; m is 0; n is integer 1-2; p is integer 0-1.
EFFECT: pharmaceutical composition including claimed compound as active component.
11 cl, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
INDOLES WITH ANTIDIABETIC ACTIVITY | 2003 |
|
RU2328483C2 |
NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
1,3,4-OXADIAZOL-2-ONES AS PPAR-DELTA MODULATORS AND APPLICATION THEREOF | 2005 |
|
RU2375358C2 |
PPAR MODULATORS | 2007 |
|
RU2449999C2 |
ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
SERINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS | 2015 |
|
RU2695649C2 |
CONDENSED AROMATIC DIFLUOROMETHANE PHOSPHONATES AS PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) INHIBITORS | 2008 |
|
RU2462469C2 |
SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
Authors
Dates
2009-05-20—Published
2005-01-18—Filed